23934135Sargis RM, Salgia RAmerican journal of clinical oncologyCarcinoma, Non-Small-Cell Lung; Lung Neoplasms; Protein Kinase Inhibitors; Pyrazoles; PyridinesAnaplastic Lymphoma Kinase; Calcium; Crizotinib; Endocrine Disruptors; Female; Humans; Hypogonadism; Insulin-Like Growth Factor I; Luteinizing Hormone; Male; Proto-Oncogene Proteins c-met; Receptor Protein-Tyrosine Kinases; Reference Values; TestosteroneMultiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non-small Cell Lung Cancer. Am J Clin Oncol. 2015 Oct; 38(5):442-7.Am J Clin Oncol2015-10-01T00:00:002015Multiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non-small Cell Lung Cancer.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD002289Disorders15810730.519149Carcinoma, Non-Small-Cell LungD007334Chemicals & Drugs611140.931793Insulin-Like Growth Factor ID008175Disorders32822600.404525Lung NeoplasmsD005260Physiology1992444050.191167FemaleD011725Chemicals & Drugs1533090.839039PyridinesD006801Living Beings2262862810.130052HumansD007006Disorders17370.958637HypogonadismD008297Physiology1931408600.201617MaleD020794Chemicals & Drugs761530.900016Receptor Protein-Tyrosine KinasesD011720Chemicals & Drugs841530.896041PyrazolesD012016Concepts & Ideas2826730.88447Reference ValuesD013739Chemicals & Drugs922680.868331TestosteroneD019859Chemicals & Drugs491990.86Proto-Oncogene Proteins c-metD002118Chemicals & Drugs28211480.692432CalciumAuthorship 6457310.5551670.2775832authors10.2517has subject areaD007986Chemicals & Drugs391670.966322Luteinizing HormoneD047428Chemicals & Drugs2065890.714193Protein Kinase InhibitorsD052244Chemicals & DrugsPhysiology10270.956405Endocrine DisruptorsMedicineUniversity of ChicagoRaviSalgiaRavi Salgia41.78927490000000-87.601250000000001937Salgia, RaviEmeritus/Emerita, Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, ProfessorAuthorship 82761